Sun Pharmaceutical Industries Balance Sheet Annual

Trade

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs

1,804.65 +6.85 (0.38%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	10,520.68	1,387.17	2,343.91	3,432.77
Short Term Investments	9,501.74	9,390.34	7,696.08	3,130.16
Cashand Short Term Investments	20,022.42	15,147.74	12,716.93	9,563.28
Accounts Receivable- Trade Net	11,249.37	11,489.29	10,513.93	9,104.23
Total Receivables Net	11,314.39	12,959.76	12,185.14	9,324.75
Total Inventory	9,868.29	10,968.32	9,239.16	9,361.80
Other Current Assets Total	2,228.01	414.35	437.15	1,913.55
Total Current Assets	43,433.11	39,861.94	34,864.60	30,442.08
Property/ Plant/ Equipment Total- Net	11,300.05	11,353.73	11,168.89	11,171.51
Goodwill Net	8,598.95	8,712.71	6,591.28	6,287.64
Intangibles Net	8,666.26	9,326.84	6,191.79	5,660.66
Long Term Investments	6,559.18	5,457.48	5,215.20	6,482.68
Note Receivable- Long Term	2,285.88	2,675.79	2,818.28	3,821.80
Other Long Term Assets Total	4,619.45	3,355.10	2,957.73	3,800.36
Total Assets	85,462.88	80,743.59	69,807.77	67,666.73
Accounts Payable	5,653.30	5,681.52	4,489.76	3,973.66
Current Portof LT Debt/ Capital Leases	2,970.05	367.70	340.07	525.55
Other Currentliabilities Total	8,360.42	6,386.17	10,426.83	8,463.20
Total Current Liabilities	16,983.77	19,906.38	17,208.45	16,145.63
Long Term Debt	1.33	0.00	229.92	654.71
Capital Lease Obligations	302.29	559.91	251.79	243.42
Total Long Term Debt	303.62	559.91	481.71	898.13
Total Debt	3,273.67	6,885.87	1,290.30	3,868.58
Deferred Income Tax	155.06	31.69	31.86	44.51
Minority Interest	3,439.22	3,320.09	3,054.89	3,017.05
Other Liabilities Total	914.46	930.14	1,019.64	1,098.63
Total Liabilities	21,796.13	24,748.21	21,796.55	21,203.95
Common Stock Total	239.93	239.93	239.93	239.93
Retained Earnings( Accumulated Deficit)	63,426.82	47,574.20	41,609.60	40,562.04
Total Equity	63,666.75	55,995.38	48,011.22	46,462.78
Total Liabilities Shareholders' Equity	85,462.88	80,743.59	69,807.77	67,666.73
Total Common Shares Outstanding	239.93	239.93	239.93	239.93
Tangible Book Valueper Share Common Eq	193.39	158.19	146.82	143.85
Cash	-	4,370.23	2,676.94	3,000.35
Prepaid Expenses	-	371.77	286.22	278.70
Property/ Plant/ Equipment Total- Gross	-	22,976.36	21,206.45	20,210.18
Accumulated Depreciation Total	-	-11,622.63	-10,037.56	-9,038.67
Accrued Expenses	-	1,512.73	1,483.27	738.32
Notes Payable/ Short Term Debt	-	5,958.26	468.52	2,444.90
Additional Paid- In Capital	-	1,187.41	1,187.41	1,187.41
Unrealized Gain( Loss)	-	214.96	162.30	428.61
Other Equity Total	-	6,778.88	4,811.98	4,044.79